Aurinia Pharmaceuticals Inc. (AUPH)
Pharmaceutical Preparations
Latest Price
$14.88
TTM P/E
6.89
Normalized P/E
168.29
Div Yield
--
Book Value
4.29
P/B Ratio
3.47
Valuation metrics
adjust assumptions →EPS: $2.07
Book value / share: $4.39
Formula: √(22.5 × EPS × BVPS)
Graham Number
$14.30
4% downside
Base FCF: $90M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$51.09
+243% upside
EPS: $2.07
Target P/E: 7×
Formula: EPS × P/E
P/E Fair Value
$14.49
3% downside
Institutional Ownership
53.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 12.23M | $181.0M | 9.35% | +900.0K | 2026-03-31 |
| BlackRock, Inc. | 7.85M | $116.0M | 6.00% | -82.6K | 2026-03-31 |
| NEA Management Company, LLC | 3.97M | $58.0M | 3.04% | -- | 2026-03-31 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.28M | $48.0M | 2.51% | -102.8K | 2026-03-31 |
| STATE STREET CORP | 2.53M | $37.0M | 1.93% | +25.1K | 2026-03-31 |
| MORGAN STANLEY | 2.23M | $33.0M | 1.71% | +15.6K | 2026-03-31 |
| MARSHALL WACE, LLP | 1.87M | $27.0M | 1.43% | +299.6K | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 1.66M | $24.0M | 1.27% | +73.7K | 2026-03-31 |
| D. E. Shaw & Co., Inc. | 1.57M | $23.0M | 1.20% | +40.7K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.54M | $22.0M | 1.17% | +28.1K | 2026-03-31 |